Argus analyst David Toung downgraded Silk Road Medical to Sell from Hold.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SILK:
- M&A News: Boston Scientific (NYSE:BSX) Will Acquire SILK For $1.2B
- Silk Road Medical downgraded to Hold from Buy at Lake Street
- Silk Road Medical to be acquired by Boston Scientific for $27.50 per share
- Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific
- Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.